VIROPTIC is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Trifluridine.
| Product ID | 61570-037_6ce5cd76-569d-4491-9b47-4b4b80e036ac |
| NDC | 61570-037 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIROPTIC |
| Generic Name | Trifluridine |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1980-04-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018299 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | TRIFLURIDINE |
| Active Ingredient Strength | 1 g/100mL |
| Pharm Classes | Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC],Nucleoside Metabolic Inhibitor [EPC],Nucleic Acid Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1980-04-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018299 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1980-04-10 |
| Marketing End Date | 2017-11-30 |
| Marketing Category | NDA |
| Application Number | NDA018299 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-04-03 |
| Marketing End Date | 2018-04-03 |
| Ingredient | Strength |
|---|---|
| TRIFLURIDINE | 1 g/100mL |
| SPL SET ID: | f3a14d86-0ff2-4535-318c-ac8bc8ede42c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 61570-037 | VIROPTIC | trifluridine |
| 50383-955 | Trifluridine | Trifluridine |
| 61314-044 | Trifluridine | trifluridine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIROPTIC 73028216 1018684 Live/Registered |
BURROUGHS WELLCOME CO. 1974-07-31 |